Zhipeng Ke
China Pharmaceutical University(CN)Kanion Pharmaceutical (China)(CN)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Pharmacological Effects of Natural Compounds, Advanced NMR Techniques and Applications, Legal and Regulatory Analysis, Linguistic, Cultural, and Literary Studies
Most-Cited Works
- → An Integrated Virtual Screening Approach for VEGFR-2 Inhibitors(2013)54 cited
- → Luteoloside Acts as 3C Protease Inhibitor of Enterovirus 71 In Vitro(2016)50 cited
- → Modification of COF-108 via impregnation/functionalization and Li-doping for hydrogen storage at ambient temperature(2017)46 cited
- → Discovery of a potent angiotensin converting enzyme inhibitor via virtual screening(2017)30 cited
- → Drug discovery of neurodegenerative disease through network pharmacology approach in herbs(2016)27 cited
- → De novo design of N-(pyridin-4-ylmethyl)aniline derivatives as KDR inhibitors: 3D-QSAR, molecular fragment replacement, protein-ligand interaction fingerprint, and ADMET prediction(2012)21 cited
- → NMR chemical shifts of urea loaded copper benzoate. A joint solid-state NMR and DFT study(2019)19 cited
- → 3D-QSAR and molecular fragment replacement study on diaminopyrimidine and pyrrolotriazine ALK inhibitors(2014)19 cited
- → Fragment-based strategy for structural optimization in combination with 3D-QSAR(2013)13 cited
- → Calculation and experimental measurement of paramagnetic NMR parameters of phenolic oximate Cu(ii) complexes(2017)13 cited